CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 146 filers reported holding CLOVIS ONCOLOGY INC in Q4 2014. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $8,870,000 | -17.4% | 168,000 | +6.3% | 1.35% | +6.8% |
| Q4 2017 | $10,744,000 | -17.5% | 158,000 | 0.0% | 1.26% | -32.1% |
| Q3 2017 | $13,019,000 | +49.5% | 158,000 | +69.9% | 1.86% | +25.6% |
| Q2 2017 | $8,708,000 | +217.3% | 93,000 | -53.5% | 1.48% | +107.7% |
| Q2 2016 | $2,744,000 | +51.3% | 200,000 | +111.6% | 0.71% | +81.2% |
| Q1 2016 | $1,814,000 | -45.2% | 94,500 | 0.0% | 0.39% | -18.8% |
| Q4 2015 | $3,308,000 | -65.7% | 94,500 | -10.0% | 0.48% | -60.7% |
| Q3 2015 | $9,656,000 | -8.4% | 105,000 | -12.5% | 1.23% | +19.3% |
| Q2 2015 | $10,546,000 | +26.3% | 120,000 | +6.7% | 1.03% | +18.9% |
| Q1 2015 | $8,348,000 | +81.9% | 112,455 | +37.2% | 0.87% | +11.1% |
| Q4 2014 | $4,589,000 | -0.8% | 81,955 | -19.6% | 0.78% | +37.0% |
| Q3 2014 | $4,625,000 | +6.4% | 101,955 | -2.9% | 0.57% | -46.7% |
| Q2 2014 | $4,348,000 | +56.9% | 105,000 | +162.5% | 1.07% | +69.4% |
| Q1 2014 | $2,771,000 | +2.2% | 40,000 | -11.1% | 0.63% | -16.2% |
| Q4 2013 | $2,712,000 | – | 45,000 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |